Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF)

Gregory Y.h. Lip, Christoph Hammerstingl, Francisco Marin, Riccardo Cappato, Isabelle Ling Meng, Bodo Kirsch, Eolo Morandi, Martin Van Eickels, Ariel Cohen

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)
708 Downloads (Pure)
Original languageEnglish
Pages (from-to)464–471.e2
JournalAmerican Heart Journal
Issue number4
Early online date6 Jan 2015
Publication statusPublished - Apr 2015

Cite this